Literature DB >> 11808714

Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry.

J Wayman1, D Forman, S M Griffin.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the reliability and adequacy of the existing system of cancer registration in the United Kingdom to monitor past and future trends in esophago-gastric cancer incidence.
METHODS: The Northern and Yorkshire UK Cancer Registry was interrogated for all cases of esophageal and gastric cancer occurring between 1984 and 1993. Data concerning year of registration, subsite, histology, sex, and ages were recorded and analyzed.
RESULTS: A total of 22,300 cases were identified from an estimated population of 6.7 million. The overall age- and sex-standardized incidence of gastric cancer fell over the 10-year period from 12.8 to 10.5 per 100,000 (p < 0.001) while esophageal cancer increased from 4.6 to 5.4 cases per 100,000 (p = 0.006). Adenocarcinoma of the gastric cardia increased in proportion from 29.1% to 52.2% (p < 0.0001), 70.4% of esophageal and 71% of gastric cancer registrations were recorded without details of subsite. For 25% of esophageal cancers and 36% of gastric cancers there was no histological information.
CONCLUSIONS: While the trend toward an increasing incidence of adenocarcinoma at the esophago-gastric junction reported in earlier studies appears to be confirmed, the high incidence of imprecise subsite reporting of cancer registry data illustrated in this study should make us look critically at the findings of other cancer registry data. Recognition of cancer of the esophago-gastric junction as distinct from other gastric and esophageal subsites may improve accuracy of recording and allow cancer registry data to more accurately monitor the changes in esophagogastric cancer incidence in subsequent analyses.

Entities:  

Mesh:

Year:  2001        PMID: 11808714     DOI: 10.1023/a:1013756531219

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  13 in total

1.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

2.  Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Melissa A Jim; Paulo S Pinheiro; Helena Carreira; David K Espey; Charles L Wiggins; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

3.  Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.

Authors:  Melina Arnold; Mathieu Laversanne; Linda Morris Brown; Susan S Devesa; Freddie Bray
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

4.  Mortality predictions for esophageal, stomach, and pancreatic cancer, Ireland, up to 2015.

Authors:  P O'Lorcain; S Deady; H Comber
Journal:  Int J Gastrointest Cancer       Date:  2006

5.  Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study).

Authors:  Shuangxi Li; Xiangji Ying; Fei Shan; Yongning Jia; Zhemin Li; Kan Xue; Rulin Miao; Yinkui Wang; Zhaode Bu; Xiangqian Su; Ziyu Li; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2022-08-30       Impact factor: 4.026

Review 6.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 7.  Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.

Authors:  Matthew F Buas; Thomas L Vaughan
Journal:  Semin Radiat Oncol       Date:  2013-01       Impact factor: 5.934

8.  Pathological factors affecting gastric adenocarcinoma survival in a Caribbean population from 2000-2010.

Authors:  Patrick O Roberts; Joseph Plummer; Pierre-Anthony Leake; Shane Scott; Tamara G de Souza; Ayesha Johnson; Tracey N Gibson; Barrie Hanchard; Marvin Reid
Journal:  World J Gastrointest Surg       Date:  2014-06-27

9.  Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan.

Authors:  Kao-Chi Cheng; Yu-Lung Chen; Shih-Wei Lai; Pang-Yao Tsai; Fung-Chang Sung
Journal:  BMC Gastroenterol       Date:  2012-12-12       Impact factor: 3.067

10.  Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?

Authors:  R E Neale; J D Doecke; N Pandeya; S Sadeghi; S Sadhegi; A C Green; P M Webb; D C Whiteman
Journal:  Br J Cancer       Date:  2009-02-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.